116 related articles for article (PubMed ID: 1671164)
1. Dopaminergic inhibition of glycoprotein hormone alpha-subunit in normal subjects.
Boesgaard S; Hagen C; Nyboe Andersen A; Agner T
Metabolism; 1991 Feb; 40(2):150-4. PubMed ID: 1671164
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenoldopam, a dopamine D-1 receptor agonist, on pituitary, gonadal and thyroid hormone secretion.
Boesgaard S; Hagen C; Andersen AN; Eldrup E; Lange P
Clin Endocrinol (Oxf); 1989 Mar; 30(3):231-9. PubMed ID: 2574081
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile gonadotropin secretion and basal prolactin levels during dopamine D-1 receptor stimulation in normal women.
Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
Fertil Steril; 1991 Feb; 55(2):281-6. PubMed ID: 1671361
[TBL] [Abstract][Full Text] [Related]
4. Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
Clin Endocrinol (Oxf); 1990 Apr; 32(4):423-31. PubMed ID: 1971778
[TBL] [Abstract][Full Text] [Related]
5. Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women.
Boesgaard S; Hagen C; Andersen AN; Fenger M; Eldrup E
Acta Endocrinol (Copenh); 1990 Jan; 122(1):29-36. PubMed ID: 1968308
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
[TBL] [Abstract][Full Text] [Related]
7. Divergent dopaminergic regulation of TSH, free alpha-subunit, and TSH-beta in pituitary cell culture.
Greenspan SL; Shupnik MA; Klibanski A; Ridgway EC
Metabolism; 1986 Sep; 35(9):843-6. PubMed ID: 2427914
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
9. Changes in circulating levels of LH, FSH, LHbeta- and alpha-subunit after gonadotropin-releasing hormone, and of TSH, LHbeta- and alpha-subunit after thyrotropin-releasing hormone.
Hagen C; McNeilly AS
J Clin Endocrinol Metab; 1975 Sep; 41(3):466-70. PubMed ID: 808557
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic regulation of gonadotropin levels and pulsatility in normal women.
Andersen AN; Hagen C; Lange P; Boesgaard S; Djursing H; Eldrup E; Micic S
Fertil Steril; 1987 Mar; 47(3):391-7. PubMed ID: 2951277
[TBL] [Abstract][Full Text] [Related]
12. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.
Agner T; Hagen C; Andersen AN; Djursing H
J Clin Endocrinol Metab; 1986 Apr; 62(4):778-82. PubMed ID: 3949956
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas.
Persani L; Beck-Peccoz P; Medri G; Conti A; Faglia G
Neuroendocrinology; 1991 Apr; 53(4):411-5. PubMed ID: 1710792
[TBL] [Abstract][Full Text] [Related]
14. A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo.
Haisenleder DJ; Dalkin AC; Ortolano GA; Marshall JC; Shupnik MA
Endocrinology; 1991 Jan; 128(1):509-17. PubMed ID: 1702704
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
Eades SC; Moore JN
Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
[TBL] [Abstract][Full Text] [Related]
16. Dopamine affects basal and augmented pituitary hormone secretion.
Leebaw WF; Lee LA; Woolf PD
J Clin Endocrinol Metab; 1978 Sep; 47(3):480-7. PubMed ID: 122408
[TBL] [Abstract][Full Text] [Related]
17. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
18. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
Popovic V; Damjanovic S
Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
[TBL] [Abstract][Full Text] [Related]
19. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Chen CJ; Apparsundaram S; Lokhandwala MF
J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
[TBL] [Abstract][Full Text] [Related]
20. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
